DaVita Inc.

DVA ·Healthcare, Medical Care Facilities, United States
Financial Statements › Income Statement
Annual Quarterly

Income Statement

Line Item Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024
Revenue $3.55B $3.42B $3.62B $3.42B $3.38B $3.22B $3.29B $3.26B
Cost of Revenue — — — — — — — —
Gross Profit — — — — — — — —
Gross Margin — — — — — — — —
Operating Expenses
Research & Development — — — — — — — —
SG&A Expense $423.5M $421.9M $472.4M $414.4M $412.8M $374.1M $414.5M $393.5M
Operating Income $579.0M $481.9M $561.1M $505.8M $537.8M $438.9M $565.4M $534.9M
Operating Margin 16.3% 14.1% 15.5% 14.8% 15.9% 13.6% 17.2% 16.4%
Interest Expense — — — — — — — —
Pretax Income $435.0M $341.2M $382.8M $308.8M $368.9M $286.3M $413.7M $373.4M
Income Tax Expense $91.8M $66.2M $76.7M $68.6M $93.7M $54.1M $64.5M $77.7M
Net Income $265.4M $197.5M $234.2M $150.3M $199.3M $162.9M $259.3M $214.7M
Net Margin 7.5% 5.8% 6.5% 4.4% 5.9% 5.1% 7.9% 6.6%
EPS (Basic) $4.10 $2.93 $3.30 $2.09 $2.62 $2.05 $3.17 $2.56
EPS (Diluted) $4.02 $2.87 $3.22 $2.04 $2.58 $2.00 $3.08 $2.50
Shares Outstanding (Basic) 64.8M 67.4M 74.2M 72.1M 75.9M 79.4M 85.0M 83.7M
Shares Outstanding (Diluted) 66.1M 68.9M 75.9M 73.8M 77.4M 81.3M 87.3M 85.8M
Dividends Per Share — — — — — — — —
← Newer Page 1 of 5 Older →